One hundred and fifteen previously untreated adults aged over 60 years were referred to St Bartholomew's Hospital between 1978 and 1986 for management of acute myeloid leukemia (AML). Twenty-seven patients received symptomatic or palliative treatment only because combination chemotherapy was conside
Serum beta 2 microglobulin in adult myeloid acute leukemias
β Scribed by Campos, L. ;Vu Van, H. ;Ville, D. ;Imbert, C. ;Gentilhomme, O. ;Luo, Y. C. ;Fiere, D. ;Viala, J. J.
- Publisher
- Springer-Verlag
- Year
- 1984
- Weight
- 351 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
β¦ Synopsis
Serum beta 2 microglobulin levels, measured by radioimmunoassay (Phadebas test), were found increased in acute myeloid leukemias at diagnosis. Serum beta 2 microglobulin levels were significantly higher in patients with monocytic leukemias (13 patients, M4-M5 FAB classification) than in those with other cytological types (18 patients). Beta 2 microglobulin levels at diagnosis were correlated with serum lysozyme levels, but they were not correlated with blood blast counts, serum LDH and ferritin levels. 195 serum beta 2 microglobulin measurements were made serially in 30 patients with acute myeloid leukemias in first remission. Compared to values at diagnosis, beta 2 microglobulin levels in remission were significantly decreased. Out of 30 patients in remission 12 had increased serum beta 2 microglobulin levels (greater than 3 mg/l). Serial measurements were not predictive for relapses.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Significantly elevated telomerase activity (TA) has been found in samples from patients with almost all malignant hematologic diseases. The impact of elevated TA on the course of pediatric patients with acute myeloid leukemia (PβAML) is unknown. ## METHODS Using a modif